Bausch + Lomb Price to Free Cash Flow Ratio 2021-2024 | BLCO
Historical price to free cash flow ratio values for Bausch + Lomb (BLCO) since 2021.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Bausch + Lomb Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2024-06-25 | 14.89 | 0.00 | |
| 2024-03-31 | 17.30 | $-0.37 | 0.00 |
| 2023-12-31 | 17.06 | $-0.56 | 0.00 |
| 2023-09-30 | 16.95 | $-0.06 | 0.00 |
| 2023-06-30 | 20.07 | $-0.16 | 0.00 |
| 2023-03-31 | 17.41 | $0.22 | 79.24 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $5.239B | $4.146B |
| Bausch Lomb Corporation is an eye health company. Its product portfolio includes Biotrue(R) and renu(R) multi-purpose solutions, Biotrue(R) ONEday daily disposable contact lenses, LUMIFY(R) redness reliever eye drops, PreserVision(R) AREDS 2 formula eye vitamin and mineral supplements and VYZULTA(R). Bausch Lomb Corporation is based in VAUGHAN, ON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.411B | 15.61 |
| Cencora (COR) | United States | $47.535B | 18.53 |
| ICON (ICLR) | Ireland | $26.024B | 24.57 |
| DiDi Global (DIDIY) | China | $21.386B | 0.00 |
| Avantor (AVTR) | United States | $14.991B | 22.07 |
| CochLear (CHEOY) | Australia | $14.406B | 0.00 |
| Natera (NTRA) | United States | $13.674B | 0.00 |
| Revvity (RVTY) | United States | $12.912B | 22.65 |
| Medpace Holdings (MEDP) | United States | $12.625B | 41.54 |
| Viatris (VTRS) | United States | $12.276B | 3.67 |
| Charles River Laboratories (CRL) | United States | $10.631B | 20.35 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.816B | 0.00 |
| Solventum (SOLV) | United States | $8.851B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.578B | 0.00 |
| HealthEquity (HQY) | United States | $7.199B | 46.22 |
| Organon (OGN) | United States | $5.347B | 5.07 |
| Doximity (DOCS) | United States | $5.140B | 36.00 |
| PACS (PACS) | United States | $4.365B | 0.00 |
| Life Times (LTH) | United States | $3.678B | 38.54 |
| Sotera Health (SHC) | United States | $3.377B | 16.57 |
| GoodRx Holdings (GDRX) | United States | $2.934B | 111.71 |
| Surgery Partners (SGRY) | United States | $2.928B | 26.79 |
| Agilon Health (AGL) | United States | $2.583B | 0.00 |
| Progyny (PGNY) | United States | $2.525B | 43.47 |
| AMN Healthcare Services Inc (AMN) | United States | $2.023B | 8.02 |
| NovoCure (NVCR) | Jersey | $1.941B | 0.00 |
| Premier (PINC) | United States | $1.936B | 8.28 |
| BrightSpring Health Services (BTSG) | United States | $1.826B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.653B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.400B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.225B | 0.00 | |
| CareDx (CDNA) | United States | $0.761B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.712B | 0.00 |
| Embecta (EMBC) | United States | $0.704B | 4.79 |
| Pediatrix Medical (MD) | United States | $0.644B | 6.83 |
| InnovAge Holding (INNV) | United States | $0.634B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.599B | 0.00 |
| Sharecare (SHCR) | United States | $0.500B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.437B | 11.45 |
| Enhabit (EHAB) | United States | $0.422B | 42.05 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.415B | 0.00 |
| ModivCare (MODV) | United States | $0.362B | 6.77 |
| Sonida Senior Living (SNDA) | United States | $0.324B | 0.00 |
| DocGo (DCGO) | United States | $0.305B | 16.67 |
| LifeMD (LFMD) | United States | $0.282B | 0.00 |
| MultiPlan (MPLN) | United States | $0.231B | 0.00 |
| Beauty Health (SKIN) | United States | $0.225B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.196B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.183B | 0.00 |
| Biodesix (BDSX) | United States | $0.181B | 0.00 |
| So-Young (SY) | China | $0.107B | 51.50 |
| Pono Capital Two (PTWO) | United States | $0.071B | 0.00 |
| NeueHealth (NEUE) | United States | $0.043B | 5.74 |
| Co-Diagnostics (CODX) | United States | $0.042B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.034B | 0.00 |
| Oncology Institute (TOI) | United States | $0.032B | 0.00 |
| Nutex Health (NUTX) | United States | $0.028B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.021B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.019B | 0.00 |
| KindlyMD (KDLY) | $0.018B | 0.00 | |
| BIMI Holdings (BIMI) | United States | $0.016B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| DermTech (DMTK) | United States | $0.004B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Assure Holdings (IONM) | United States | $0.002B | 0.00 |